Log In
Print
BCIQ
Print
Print this Print this
 

RSLV-132

  Manage Alerts
Collapse Summary General Information
Company Resolve Therapeutics LLC
DescriptionMono-specific nuclease Fc-fusion protein that targets and removes immune complexes which are activating the inflammatory cascade
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today